Amy S. Broidrick's most recent trade in Qualigen Therapeutics Inc was a trade of 130,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on July 11, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Qualigen Therapeutics Inc | Amy S. Broidrick | Director, President/CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jul 2022 | 130,000 | 130,000 | - | - | Stock Option (Right to Buy) | |
| Qualigen Therapeutics Inc | Amy S. Broidrick | Director, President/CSO | Purchase of securities on an exchange or from another person at price $ 0.62 per share. | 14 Jun 2022 | 30,000 | 34,500 | - | 0.6 | 18,600 | Common Stock |
| Qualigen Therapeutics Inc | Amy S. Broidrick | Director, President/ChiefStrategyOfficer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2021 | 300,000 | 300,000 | - | - | Stock Option (Right to Buy) | |
| Qualigen Therapeutics Inc | Amy S. Broidrick | Director, EVP, Chief Strategy Officer | Purchase of securities on an exchange or from another person at price $ 2.03 per share. | 26 Apr 2021 | 4,500 | 4,500 | - | 2.0 | 9,135 | Common Stock |
| Qualigen Therapeutics Inc | Amy S. Broidrick | Director, Executive VP, CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Dec 2020 | 150,000 | 150,000 | - | - | Stock Option (Right to Buy) |